Straight from the President's Letter, diversifying
Post# of 1609
Posted On: 01/21/2014 5:32:29 PM
Straight from the President's Letter, diversifying Solos product pipeline in addition to the MammoView product line with new devices to examine other organs and tissues expands its product offerings. Cheers!
"...Looking forward in 2014, Solos Endoscopy’s ISO 13485:2003 certification will allow
the company to sell the MammoView® product line in Europe and Canada. As
part of the process to obtain the CE Mark, Solos Endoscopy retained Emergo
Group to act as the Company's authorized representative in Europe. Emergo
Group will provide Solos assistance related to communications with authorities
and importation of Solos instruments into Europe
Solos has several exciting new advances in product development that will
change the way minimally invasive procedures are utilized in the medical field in
order to treat and prevent disease. These products will allow the physician to
examine organs and tissues within the body without the need for intrusive
surgery. The Company is currently marketing its next generation breast
endoscopy system, the MammoView® system, for early breast cancer detection
..."
..."
(0)
(0)CYduct Diagnostics Inc. (CYDX) Stock Research Links
Scroll down for more posts ▼